ECRI (Organization) (2006). Evidence Report: Licit Schedule II Drug Use and Commercial Motor Vehicle Driver Safety (Comprehensive Review). United States. Department of Transportation. Federal Motor Carrier Safety Administration. https://doi.org/10.21949/1502993
ECRI (Organization). Evidence Report: Licit Schedule II Drug Use and Commercial Motor Vehicle Driver Safety (Comprehensive Review). United States. Department of Transportation. Federal Motor Carrier Safety Administration, 2006. https://doi.org/10.21949/1502993.
ECRI (Organization) Evidence Report: Licit Schedule II Drug Use and Commercial Motor Vehicle Driver Safety (Comprehensive Review). United States. Department of Transportation. Federal Motor Carrier Safety Administration, 2006, ROSA P. https://doi.org/10.21949/1502993.
Details
Alternative Title:
Licit schedule II drug use and commercial motor vehicle driver safety (comprehensive review)
;
FMCSA evidence report: licit schedule II drug use and commercial motor vehicle driver safety (comprehensive review)
NTL-FREIGHT-Trucking Industry
;
NTL-SAFETY AND SECURITY-Human Factors
Abstract:
Of all occupations in the United States, workers in the trucking industry experience the third-highest fatality rate, accounting for 12 percent of all worker deaths. About two-thirds of fatally injured truck workers were involved in highway crashes. According to statistics from the United States Department of Transportation for 2005, 137,144 crashes involved a large truck. Of these, 59,405 were crashes that resulted in an injury to at least one individual for a total of 89,681 injuries. In 2004,1 4,862 large trucks were involved in fatal crashes for a total of 5,190 fatalities. The purpose of this evidence report is to examine the relationship between the licit use of a Schedule II drug and the risk for a motor vehicle crash.
ECRI (Organization) (2006). Evidence Report: Licit Schedule II Drug Use and Commercial Motor Vehicle Driver Safety (Comprehensive Review). United States. Department of Transportation. Federal Motor Carrier Safety Administration. https://doi.org/10.21949/1502993
ECRI (Organization). Evidence Report: Licit Schedule II Drug Use and Commercial Motor Vehicle Driver Safety (Comprehensive Review). United States. Department of Transportation. Federal Motor Carrier Safety Administration, 2006. https://doi.org/10.21949/1502993.
ECRI (Organization) Evidence Report: Licit Schedule II Drug Use and Commercial Motor Vehicle Driver Safety (Comprehensive Review). United States. Department of Transportation. Federal Motor Carrier Safety Administration, 2006, ROSA P. https://doi.org/10.21949/1502993.
ROSA P serves as an archival repository of USDOT-published products including scientific
findings, journal articles, guidelines, recommendations, or other information authored or co-authored by
USDOT or funded partners. As a repository, ROSA P retains documents in their original published format to
ensure public access to scientific information.
Links with this icon indicate that you are leaving a Bureau of Transportation
Statistics (BTS)/National Transportation Library (NTL)
Web-based service.
Thank you for visiting.
You are about to access a non-government link outside of
the U.S. Department of Transportation's National
Transportation Library.
Please note: While links to Web sites outside of DOT are
offered for your convenience, when you exit DOT Web sites,
Federal privacy policy and Section 508 of the Rehabilitation
Act (accessibility requirements) no longer apply. In
addition, DOT does not attest to the accuracy, relevance,
timeliness or completeness of information provided by linked
sites. Linking to a Web site does not constitute an
endorsement by DOT of the sponsors of the site or the
products presented on the site. For more information, please
view DOT's Web site linking policy.
To get back to the page you were previously viewing, click
your Cancel button.